Stem Pharm Joins Merck Digitial Sciences Studio Accelerator Program To Drive Innovations InNeurological Drug Discovery
Stem Pharm, Inc. announced today that the company has joined the first biopharmaceutical cohort ofMerck Digital Sciences Studio (“MDSS”). MDSS is a collaboration between Merck, Microsoft for Startups,and the New Jersey Innovation Institute, a New Jersey Institute of Technology subsidiary,…